Description
A metabolite of itraconazole; exhibits in vitro antifungal activity (MIC = 0.019, 0.078, 0.078 mg/ml against C. albicans, A. fumigatus, and C. neoformanss, respectively); plasma concentration is used as an indicator of prophylaxis for fungal infections,
Formal name: 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(2-hydroxy-1-methylpropyl)-3H-1,2,4-triazol-3-one
Synonyms: hydroxy-ITZ|OH-ITZ
Molecular weight: 721.6
CAS: 112559-91-8
Purity: ≥95% (mixture of diastereomers)
Formulation: A solid
Product Type|Biochemicals|Antifungals|Triazoles||Product Type|Biochemicals|Small Molecule Activators||Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Fungal Diseases|Aspergillosis||Research Area|Infectious Disease|Fungal Diseases|Candidiasis||Research Area|Toxicology|Drug Metabolism|Cytochrome P450||Research Area|Toxicology|Drug Metabolism|Drug Metabolites